Disclosure Quest - Search SEC Filings

More options

Type of Offering

Amount To Be Raised

to

Filing Date

to

Type of Security

Industry

CIK Number

Principal Place Of Business

Found 5 results

Name	Type of Offering	Accepted Date
Flow Pharma, Inc. See All Filings	D/A	2024-08-08 12:30:25 UTC
Amount To Be Raised $40,000,000 Associated Brokers / Dealers N/A CIK Number 0001732825 Filed Document 0001732825-24-000003 Exclusions or Exemptions 506b Accepted Date 2024-08-08 12:30:25 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business OHIO Revenue or Assets Decline to Disclose Type of Security Equity
Flow Pharma, Inc. See All Filings	D	2024-08-01 16:52:01 UTC
Amount To Be Raised $40,000,000 Associated Brokers / Dealers N/A CIK Number 0001732825 Filed Document 0001732825-24-000001 Exclusions or Exemptions 506b Accepted Date 2024-08-01 16:52:01 UTC Type of Offering D Industry Biotechnology Principal Place of Business OHIO Revenue or Assets Decline to Disclose Type of Security Equity
Flow Pharma, Inc. See All Filings	D	2022-11-02 09:01:50 UTC
Amount To Be Raised $10,500,000 Associated Brokers / Dealers Carleton McKenna Advisors, LLC CIK Number 0001732825 Filed Document 0001732825-22-000003 Exclusions or Exemptions 506c Accepted Date 2022-11-02 09:01:50 UTC Type of Offering D Industry Biotechnology Principal Place of Business OHIO Revenue or Assets Decline to Disclose Type of Security Equity
Flow Pharma, Inc. See All Filings	D	2018-02-28 15:45:42 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001732825 Filed Document 0001732825-18-000003 Exclusions or Exemptions 506b Accepted Date 2018-02-28 15:45:42 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Debt
Flow Pharma, Inc. See All Filings	D	2018-02-28 15:16:48 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001732825 Filed Document 0001732825-18-000002 Exclusions or Exemptions 506b Accepted Date 2018-02-28 15:16:48 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity